fluticasone/salmeterol in all asthmatics
ApprovedSmall molecule
fluticasone/salmeterol in all asthmatics is one of 21 small molecule programs targeting Asthma. It is currently in Approved.
1
Indications
1
Total Trials
1
Active Trials
20
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
1050 competitors in Asthma
#DrugCompanyPhaseTrials
1fluticasone/salmeterol in all asthmatics
GGelb, Arthur F., M.D.
Approved
Cinqair
TevaPreclinical
Qvar
Chiesi Farmaceutici S.p.A.Preclinical
Spiriva
Boehringer IngelheimPreclinical
Formoterol Fumarate
AstraZenecaPreclinical
Atrovent
Boehringer IngelheimPreclinical
Aciphex
Akero TherapeuticsPreclinical
Blood Withdrawn
Emergent BioSolutionsPreclinical
Lexapro
SShirley Ryan AbilityLab
Preclinical
Ozone
TTanta University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Approved[1]
- Company
- GGelb, Arthur F., M.D.